{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:43Z","timestamp":1790283883045,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1213\/ane.0b013e31828a71ff","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T06:05:27Z","timestamp":1365141927000},"page":"1078-1086","source":"Crossref","is-referenced-by-count":65,"title":["Ryanodine Receptor Type 1 Gene Variants in the Malignant Hyperthermia-Susceptible Population of the United States"],"prefix":"10.1213","volume":"116","author":[{"given":"Barbara W.","family":"Brandom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiid","family":"Bina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarina","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Visoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Isackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgirene D.","family":"Vladutiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyamkhishig","family":"Sambuughin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila M.","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210902","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1034\/j.1399-6576.2002.460610.x","article-title":"Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.","volume":"46","author":"Rueffert","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"R2-20-20210902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","article-title":"Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.","volume":"26","author":"Monnier","year":"2005","journal-title":"Hum Mutat"},{"key":"R3-20-20210902","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"R5-20-20210902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia.","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"R6-20-20210902","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12630-011-9494-6","article-title":"Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.","volume":"58","author":"Kraeva","year":"2011","journal-title":"Can J Anaesth"},{"key":"R7-20-20210902","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1399-0004.2010.01493.x","article-title":"Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families.","volume":"79","author":"Tammaro","year":"2011","journal-title":"Clin Genet"},{"key":"R8-20-20210902","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies.","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"R9-20-20210902","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000542-200109000-00009","article-title":"North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.","volume":"95","author":"Sambuughin","year":"2001","journal-title":"Anesthesiology"},{"key":"R10-20-20210902","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200410000-00005","article-title":"Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.","volume":"101","author":"Sei","year":"2004","journal-title":"Anesthesiology"},{"key":"R11-20-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R12-20-20210902","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"R13-20-20210902","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/9.18.2599","article-title":"An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.","volume":"9","author":"Monnier","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R14-20-20210902","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ymgme.2011.07.001","article-title":"Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies.","volume":"104","author":"Vladutiu","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R15-20-20210902","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","article-title":"Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.","volume":"19","author":"Jungbluth","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"R16-20-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R17-20-20210902","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/321270","article-title":"Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.","volume":"69","author":"Sambuughin","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R18-20-20210902","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1034\/j.1399-0004.2002.620111.x","article-title":"Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia.","volume":"62","author":"McWilliams","year":"2002","journal-title":"Clin Genet"},{"key":"R19-20-20210902","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nmd.2004.03.011","article-title":"Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.","volume":"14","author":"Wehner","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R20-20-20210902","first-page":"115","article-title":"Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.","volume":"36","author":"Barone","year":"1999","journal-title":"J Med Genet"},{"key":"R21-20-20210902","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0143-4160(02)00138-0","article-title":"Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.","volume":"32","author":"Galli","year":"2002","journal-title":"Cell Calcium"},{"key":"R22-20-20210902","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1373\/49.5.761","article-title":"Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.","volume":"49","author":"Tammaro","year":"2003","journal-title":"Clin Chem"},{"key":"R23-20-20210902","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/brain\/awl077","article-title":"Central core disease is due to RYR1 mutations in more than 90 of patients.","volume":"129","author":"Wu","year":"2006","journal-title":"Brain"},{"key":"R24-20-20210902","first-page":"67","article-title":"RYR1-related central core myopathy in a Chinese adolescent boy.","volume":"17","author":"Chan","year":"2011","journal-title":"Hong Kong Med J"},{"key":"R25-20-20210902","first-page":"543","article-title":"Gene symbol: RYR1. Disease: malignant hyperthermia.","volume":"118","author":"Dekomien","year":"2005","journal-title":"Hum Genet"},{"key":"R26-20-20210902","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/humu.20696","article-title":"Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.","volume":"29","author":"Monnier","year":"2008","journal-title":"Hum Mutat"},{"key":"R27-20-20210902","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0310057X0803600311","article-title":"Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.","volume":"36","author":"Gillies","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"R28-20-20210902","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0b013e318182a93b","article-title":"Novel ryanodine receptor mutation that may cause malignant hyperthermia.","volume":"109","author":"Kaufmann","year":"2008","journal-title":"Anesthesiology"},{"key":"R29-20-20210902","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.59.2.284","article-title":"Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores.","volume":"59","author":"Jungbluth","year":"2002","journal-title":"Neurology"},{"key":"R30-20-20210902","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R31-20-20210902","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/jmg.2003.014274","article-title":"RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene.","volume":"41","author":"Shepherd","year":"2004","journal-title":"J Med Genet"},{"key":"R32-20-20210902","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0960-8966(02)00135-9","article-title":"The spectrum of pathology in central core disease.","volume":"12","author":"Sewry","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"R33-20-20210902","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/adc.88.12.1051","article-title":"Central core disease: clinical, pathological, and genetic features.","volume":"88","author":"Quinlivan","year":"2003","journal-title":"Arch Dis Child"},{"key":"R34-20-20210902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0960-8966(02)00218-3","article-title":"Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.","volume":"13","author":"Davis","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"R35-20-20210902","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility.","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"R36-20-20210902","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000542-200203000-00038","article-title":"Delayed postoperative rhabdomyolysis in a patient subsequently diagnosed as malignant hyperthermia susceptible.","volume":"96","author":"McKenney","year":"2002","journal-title":"Anesthesiology"},{"key":"R37-20-20210902","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes.","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"R38-20-20210902","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00000542-199803000-00007","article-title":"Bayesian modeling of muscle biopsy contracture testing for malignant hyperthermia susceptibility.","volume":"88","author":"Loke","year":"1998","journal-title":"Anesthesiology"},{"key":"R39-20-20210902","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10877-011-9285-1","article-title":"A case of malignant hyperthermia captured by an anesthesia information management system.","volume":"25","author":"Maile","year":"2011","journal-title":"J Clin Monit Comput"},{"key":"R40-20-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R41-20-20210902","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","article-title":"The sensitivity and specificity of the caffeine-halothane contracture test, a report from the North American Malignant Hyperthermia Registry.","volume":"88","author":"Allen","year":"1998","journal-title":"Anesthesiology"},{"key":"R42-20-20210902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00003643-200402000-00012","article-title":"Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.","volume":"21","author":"Ginz","year":"2004","journal-title":"Eur J Anaesthesiol"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e31828a71ff","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:20:52Z","timestamp":1786112452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201305000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31828a71ff","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718030795.793480308","asserted-by":"object"}]},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}